Efficacy and safety of once-weekly insulin icodec versus once-daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials
EndocrinologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Diabetes, obesity & metabolism
- Publicado em
- 30 set 2024
- Citações
- 7
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Efficacy and safety of once-weekly insulin icodec versus once-daily basal insulin in Japanese individuals with type 2 diabetes: A subgroup analysis of the ONWARDS 1, 2 and 4 trials
Hirotaka Watada, Björg Ásbjörnsdóttir, Tomoyuki Nishida, Rimei Nishimura, Yuiko Yamamoto, Toshimasa Yamauchi, Takashi Kadowaki
Descritores MeSH
- Insulin, Long-Acting
- Blood Glucose
- Diabetes Mellitus, Type 2
- Drug Administration Schedule
- Glycated Hemoglobin
- Hypoglycemia
- Hypoglycemic Agents
- Insulin Glargine
- Male
- Humans
Veja também
Estudos relacionados
- Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg as an Add-On to Dose-Reduced Insulin Glargine versus Dose-Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight (SUSTAIN OPTIMIZE)
- Durabilidade e Segurança da Imeglimina como Inibidores Adicionais de DPP-4 em Diabetes Tipo 2 Japonês: O ensaio FAMILIAR de 104 semanas
- Impact of Time of Injection on the Efficacy and Safety of iGlarLixi Versus IDegAsp in Chinese People With Type 2 Diabetes: Exploratory Analysis of the Soli-D Study
- The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli-D randomized controlled trial